JP2001525843A - Method for producing deoxyuridine derivative - Google Patents
Method for producing deoxyuridine derivativeInfo
- Publication number
- JP2001525843A JP2001525843A JP54999498A JP54999498A JP2001525843A JP 2001525843 A JP2001525843 A JP 2001525843A JP 54999498 A JP54999498 A JP 54999498A JP 54999498 A JP54999498 A JP 54999498A JP 2001525843 A JP2001525843 A JP 2001525843A
- Authority
- JP
- Japan
- Prior art keywords
- fluorouridine
- phenyl
- formula
- deoxy
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 4
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical class C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 title description 3
- ZWAOHEXOSAUJHY-ZIYNGMLESA-N doxifluridine Chemical compound O[C@@H]1[C@H](O)[C@@H](C)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ZWAOHEXOSAUJHY-ZIYNGMLESA-N 0.000 claims abstract description 13
- KTXQKYNSEWRSDM-UAKXSSHOSA-N 1-[(2r,3r,4s,5s)-3,4-dihydroxy-5-(iodomethyl)oxolan-2-yl]-5-fluoropyrimidine-2,4-dione Chemical compound O1[C@H](CI)[C@@H](O)[C@@H](O)[C@@H]1N1C(=O)NC(=O)C(F)=C1 KTXQKYNSEWRSDM-UAKXSSHOSA-N 0.000 claims abstract description 12
- LHTMLCXJMYPWGR-NPDIDSPYSA-N 5-fluoro-1-[(4r,6r)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidine-2,4-dione Chemical compound N1([C@@H]2O[C@H](CO)C3OC(OC32)(C)C)C=C(F)C(=O)NC1=O LHTMLCXJMYPWGR-NPDIDSPYSA-N 0.000 claims abstract description 6
- 229910001516 alkali metal iodide Inorganic materials 0.000 claims abstract description 3
- 229910001619 alkaline earth metal iodide Inorganic materials 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 claims description 10
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 239000000852 hydrogen donor Substances 0.000 claims description 7
- -1 tri-substituted phenyl group Chemical group 0.000 claims description 7
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 6
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 claims description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 229940043279 diisopropylamine Drugs 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims description 2
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims description 2
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052736 halogen Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical group 0.000 claims description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 150000003335 secondary amines Chemical class 0.000 claims 2
- 150000003512 tertiary amines Chemical class 0.000 claims 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical group [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 abstract description 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 2
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 150000008266 deoxy sugars Chemical class 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229950005454 doxifluridine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000002050 international nonproprietary name Substances 0.000 description 1
- 239000012336 iodinating agent Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Abstract
(57)【要約】 2’,3’−O−イソプロピリデン−5−フルオロウリジンを対応する5’−O−スルホニル誘導体に変換すること、続いて、アルカリ金属ヨウ化物又はアルカリ土類金属ヨウ化物と反応させること、そしてイソプロピリデン基の加水分解後に、このようにして得られた5’−デオキシ−5’−ヨード−5−フルオロウリジンを還元することを含むところの、5’−デオキシ−5−フルオロウリジンの製造方法が開示されている。 (57) [Summary] Converting 2 ', 3'-O-isopropylidene-5-fluorouridine to the corresponding 5'-O-sulfonyl derivative, followed by reacting with an alkali metal or alkaline earth metal iodide; A method for producing 5'-deoxy-5-fluorouridine, comprising reducing the 5'-deoxy-5'-iodo-5-fluorouridine thus obtained after hydrolysis of the isopropylidene group. Is disclosed.
Description
【発明の詳細な説明】 デオキシウリジン誘導体の製造方法 本発明は、デオキシウリジン誘導体の製造方法に関する。更に詳しくは、本発 明は、5’−デオキシ−5−フルオロウリジン並びにこの方法において有用な新 規な中間体の製造方法に関する。 化合物5’−デオキシ−5−フルオロウリジンは、そのInternational Nonpro prietary Nameドキシフルリジン(doxifluridine)により下記において示されるで あろうところの周知の細胞静止剤である。 式Iを持つドキシフルリジンは、 米国特許第4,071,680号明細書に開示されており、ここで、5−フルオ ロウリジンから開始し、そして対応する5’−ヨウ素誘導体を通じての5’−ヒ ドロキシ基の除去を含む多段階合成がまた開示されている。この文献によれば、 ヨウ素原子による5’−ヒドロキシ基の置換えは、反応副生成物の存在に帰する 試薬の毒性の故に特定の注意を必要とするところの化学ヨウ素化剤としてトリフ ェニルホスファイトメソアイオダイドを使用することにより達成 される。 欧州特許第21,231号公報は、対応する、カルボン酸を持つ2’,3’− ジエステル、とりわけ対応する2’,3’−ジアセテートからのアシル基の除去 によるドキシフルリジンの製造を開示している。しかし、出発物質の合成は、臭 素原子によるヒドロキシ基の置換え、及び接触水素化により臭素誘導体を対応す るデオキシ化合物に転換することを含む。この場合においてまた、臭素化は、蛍 光化合物を使用して、即ち、大量のトリフェニルホスフィンの存在下に臭素を用 いて実行される。 S.Aymera及びP.V.Danenberg(J.Med.Chem.1982年、25 号、第999頁)による論文によれば、5’−デオキシ−5’−ヨード−2’,3 ’−O−イソプロピリデン−5−フルオロウリジンは、米国特許第4,071, 680号明細書に対応するところのCookらの方法(J.Med.Chem.1979年、22号 、第1330頁)に従って製造される。同一の論文は、臭化リチウムにより5’−デ オキシ−5’−O−メシルオキシ−2’,3’−O−イソプロピリデン−5−フ ルオロウリジンを5’−ブロモ−5’−デオキシ−2’,3’−O−イソプロピ リデン−5−フルオロウリジンへ転換することを開示しているが、それは、何ら 更なる転換を開示していない。 一方、上記において引用した欧州特許第21,231号公報において、水素原 子による臭素原子の置換えは、強力な条件下、即ち、ウラシル部分を含まない基 体上で水酸化 カリウムの存在下における接触水素化により行われ、ここで、その一つは、強い 無機塩基の存在下にデオキシ糖の製造後に導入される。 もし、2’,3’−イソプロピリデン−5−フルオロウリジンのヒドロキシ基 がスルホン酸エステルのように予め活性化されるなら、任意の蛍光化合物の不存 在下に、単純にヨウ化ナトリウムを使用することによりヨウ素原子によって2’ ,3’−イソプロピリデン−5−フルオロウリジンのヒドロキシル基を置換え得 ることが今見出された。 5’−デオキシ−5’−ヨード−2’,3’−O−イソプロピリデン−5−フ ルオロウリジンのヨウ素原子が、強塩基を使用することなしに接触水素化により 水素原子によって置換えられることができて、従って、非常に良好な収率で対応 する5’−デオキシ化合物が得られることがまた見出された。同一の置換えが、 他の水素供与体、例えば、シクロヘキセン、シクロヘキサジエン又は水素化物、 例えば、トリブチルスズ水素化物により起り得る。 従って、 (a)式IIの2’,3’−O−イソプロピリデン−5−フルオロウリジン を式IIIのスルホン酸の官能性誘導体 [ここで、Rは、(C1〜C4)アルキル、トリフルオロメチル、非置換のフェニ ル基、又はモノ−、ジ−若しくはトリ置換されたフェニル基である] と反応させること、 (b)このようにして得られた式IVの5’−スルホニルオキシ誘導体 (ここで、Rは上記と同じである) をアルカリ金属ヨウ化物又はアルカリ土類金属ヨウ化物と反応させること、 (c)このようにして得られた式Vの5’−デオキシ−5’−ヨード−2’,3 ’−O−イソプロピリデン−5−フルオロウリジンを酸性媒体中で加水分解すること、及び (d)式VIの5’−デオキシ−5’−ヨード−5−フルオロウリジン を水素又は水素供与体による還元に付すること を含むところの5’−デオキシ−5−フルオロウリジンの 製造方法を提供することが本発明の目的である。 式IIIにおいて、Rは、好ましくはメチル、エチル、n−ブチル、トリフルオ ロメチル、フェニル、一置換されたフェニル、即ち、メチル、メトキシ、ニトロ 基若しくはハロゲンにより一置換されたフェニル、二置換されたフェニル、即ち 、二つのメチル基により二置換されたフェニル、又は三置換されたフェニル、即 ち、三つのメチル基により三置換されたフェニル、とりわけ、2,4,6−三置 換されたフェニルである。 スルホン酸の官能性誘導体として、クロリド、酸無水物又は混合酸無水物が適 切に使用される。メタンスルホニルクロリド、ベンゼンスルホニルクロリド、p −トルエンスルホニルクロリド、トリフルオロメタンスルホニルクロリド及び2 ,4,6−トリメチルフェニルスルホニルクロリドが、エステル化剤としてとり わけ好ましい。 このように、工程(a)において、好ましくは、上記において定義されたもの から成る群から選ばれた式IIIのスルホン酸の官能性誘導体は、2’,3’−O −イソプロピリデン−5−フルオロウリジンと反応させられる。有利に、該反応 は、有機溶媒、即ち、ハロゲン化溶媒、例えば、ジクロロメタン、1,2−ジク ロロエタン若しくは1,1,1−トリクロロエタン、又は極性非プロトン性溶媒 、例えば、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、ジ メチルスルホキシド若しくはアセトニトリル、又はエチ ルアセテート又は芳香族炭化水素、例えば、トルエン若しくはキシレン中で、塩 基、例えば、トリメチルアミン、トリエチルアミン、ジイソプロピルアミン、N −エチル−ジイソプロピルアミン、ピリジン又はジメチルアミノピリジンの存在 下に実行される。 通常、0++40℃の温度で5÷6時間後、反応は完了し、そしてこのように して得られた式IVの化合物は、水で処理した後、反応副生成物の単純な濾過によ り反応副生成物から分離される。 式IVの5’−スルホニルオキシ誘導体は、有機溶媒による抽出、続く濃縮によ り回収されることができ、そして慣用の方法に従って、単離かつ特性化され得る 。 あるいは、式IVの化合物の濃縮された溶液が、工程(b)のために直接的に使 用されてよい。 工程(b)は、式IVの化合物を、純粋な形態において、もしくは、工程(a) の最後で得られる前記濃縮された溶液として、ケトン、好ましくはアセトン、メ チルエチルケトン、もしくはメチルイソブチルケトン、エーテル、好ましくはジ オキサン、もしくはテトラヒドロフラン、または極性の非プロトン性溶媒、好ま しくはアセトニトリル、N,N−ジメチルフォルムアミド、N,N−ジメチルアセ トアミド、もしくはジメチルスルフォキサイド等の有機溶媒中のアルカリもしく はアルカリ土類よう化物を用いて、簡便に処理して行われる。 40〜80℃の温度で4〜6時間後、該反応は完結し、工 程(a)におけるように、該反応の副生成物が濾過により除去され、そして、水 によって洗浄される。予想される最終生成物、すなわち、式Vの5’−デオキシ −5’−ヨード−2’,3’−O−イソプロピリデン−5−フルオロウリジンは有機 溶媒、好ましくは酢酸エチルを用いて回収され、次いで、濃縮され、及び従来の 方法に従い単離されてよい。工程(a)におけるように、式Vの化合物を含む濃 縮された溶液は、工程(c)のために直接使用されてよい。 工程(c)は、糖化学分野、より特にはヌクレオシドの分野、で慣用されてい る方法に従う、5’−デオキシ−5’−ヨード−2’,3’−O−イソプロピリデン −5−フルオロウリジンの酸性媒体中での加水分解からなる。好ましくは、該加 水分解は水性のぎ酸中で、もしくは、より有利には、水性の酢酸中で、又はN, N−ジメチルフォルムアミド中もしくはN,N−ジメチルアセトアミド中で、水 性の塩化水素の存在下で、80〜100℃にて行われる。 かくして得られる式VIの5’−デオキシ−5’−ヨード−5−フルオロウリジン は、溶媒を蒸発させることによって単離され、そして該化合物は抽出によって、 好適な溶媒、好ましくは酢酸エチルから回収される。 上述したように、工程(a)及び(b)の最後に得られる化合物は、単離され 、及び同定されてよく、又は好ましくは、それらは単離されることなく、生の状 態で、又は溶媒に溶解もしくは懸濁された状態で、使用されてよい。3つの工程 の収率は大変に高く、すなわち、常に理論量の 90%より高く、式VIの化合物は、出発物質である式IIの2’,3’−O−イソプロ ピリデン−5−フルオロウリジンに基づく計算で、83〜85%もの高さで回収され る。 工程(d)において、式VIの化合物は還元に付され、該還元は触媒的な水素化 又はシクロヘキサンもしくはシクロヘキサジエンを水素供与体として使用して、 例えば触媒として、好ましくは5%のPd/Cの存在下で、もしくは水素化物によ っても、行われてよい。 該還元は、有機溶媒中、例えばアルコール中、例えばメタノール、エタノール 、プロパノール、イソプロパノール、もしくはn−ブタノールまたはこれらの混 合物中で行われる。好ましくは、有機塩基、例えばトリメチルアミン、トリエチ ルアミン、ジイソプロピルアミン、N−エチルジイソプロピルアミン、ピリジン 、ジメチルアミノピリジン、モルフォリン、N−メチルモルフォリン、2−ピコ リン、及びキノン、又は無機塩基、例えば炭酸水素アルカリ塩、例えば炭酸水素 ナトリウム、もしくは炭酸水素カリウム、が反応混合物中に存在する。 還元が水素によって行なわれる場合には、水素化は室温で、又は、1〜2bar の圧力で且つ室温で、5%Pd/Cの存在下で起こる。 還元が水素供与体、例えばシクロヘキサン、シクロヘキサジエンもしくは水素 化物、例えば水素化トリブチル錫、の存在下で行なわれる場合には、該反応はア ルコール性溶媒中、例えばメタノール、エタノール、イソプロパノール、 n−ブタノール、イソブタノール等、もしくは、前記溶媒と非プロトン性溶媒、 例えばトルエン、との混合物中で行われる。 より特には、還元が、水素供与体としてのシクロヘキサン又はシクロヘキサジ エンによって、60〜90℃で行なわれる場合には、3〜6時間後に完結する。 このようにして得られる5’−デオキシ−5−フルオロウリジンは、従来の方法 に従い、より特には、触媒を濾過し及び溶媒を蒸発させて、単離される。最終生 成物はエタノール/イソプロパノール=3/2(体積/体積)混合物を用いて晶出 される。 還元が、水素化トリブチル錫を用いて行なわれる場合には、該反応は5’−デ オキシ−5’−ヨード−5−フルオロウリジンをアルコール、例えばメタノール、 に溶解して、還元剤を有機溶媒中、例えばトルエン中、の溶液として加えて行わ れ、該反応混合物は、触媒量のα,α’−アゾイソブチロニトリルの存在下で、 加熱されて還流する。1〜3時間後に反応は完結し、そして溶媒の蒸発後に、こう して得られた5’−デオキシ−5−フルオロウリジンが、従来の方法に従い回収さ れる。 本発明の好ましい実施態様に従い、工程(a)、(b)及び(c)は工程(a )及び(b)の各々の最後に得られる生成物を単離することなく行われる。この ようにして、本発明の方法はドキシフルリジン(doxifluridine)を非常に容易に 、且つ非常に高い収率で調製することを可能にする。 加えて、この方法は工程(a)、(b)及び(c)に関してワンポット法(the o ne-pot technique)で行なってよい。該方法はスキームIに表されており、ここ でRは(C1〜C4)アルキル、トリフルオロメチル、非置換の、又はモノ−、ジ −もしくはトリ置換フェニルである。 スキーム1 以下の実施例は、本発明を限定することなく説明する。 実施例 1 約+5℃に冷却された、700mlのピリジン中の80g(0.26 m)の2’,3’−O−イソプロピリデン−5−フルオロウリジンの溶液に、90.6 g(0.48m)のp−トルエンスルフォニルクロライドを添加した。得られた混合物 を5時間攪拌し、次いで、10リットルの水をゆっくり加え、そして水性の懸濁物 を3時間攪拌した。該混合物を室温で15時間放置し、次いで、沈澱物を濾過し、 水洗し、そして乾燥した。このようにして、結晶形態の2’,3’−O−イソプロ ピリデン−5’−O−(p−トルエンスルフォニル)−5−フルオロウリジンが得 られた。M.p.=154〜156℃;純度(HPLC)=99.89%および[α]D=+26.7 1°(c=1、CH3OH)。 このようにして得られた生成物を、エタノールを用いて結晶出させて、白色の 結晶性粉体を得ることができる。M.p.=156〜158℃;純度=99.9〜100%(HPL C)。 実施例2 A.5'−デオキシ−5'−ヨード−5−フルオロウリジン 塩化メチレン55mlおよびピリジン159ml(1.98m)中の2',3'−O−イソプ ロピリデン−5−フルオロウリジン39.2g(0.13m)の溶液を+5℃に冷却し、 これに塩化p−トルエンスルホニル60g(0.315m)を添加する。こうして得ら れた混合物を5時間攪拌すると、多量の沈殿の生成が認められる。次いで、160m lの塩化メチレンおよび160mlの水をその中に添加し、それによって温度が40℃に 上昇する。相を分離し、有機相を約900mlの1N HClで抽出する。次いで、 有機相を2x100mlの 水で洗浄する。0.117mの2',3'−O−イソプロピリデン−5'−O−(p−ト ルエンスルホニル)−5−フルオロウリジン(収率:理論量の90%)を含む有機 相を、油状残渣が得られるまで減圧濃縮し、これを2x100mlのアセトンに吸収 させる。油状残渣を600mlのアセトンに溶解し、105g(0.70m)のヨウ化ナトリ ウムをその溶液に添加する。混合物を還流下で5時間加熱し、次いで冷却し、減 圧濃縮し、こうして得られた残渣を2x80mlの酢酸エチルに吸収させる。残留油 状物を800mlの酢酸エチルおよび100mlの水で処理する。相を分離し、水性層を2 x80mlの酢酸エチルで処理する。有機相を集めて2x100mlのメタ重亜硫酸ナト リウムの5%水性溶液、次いで100mlの水で洗浄する。0.113mの5'−デオキシ −5'−ヨード−2',3'−O−イソプロピリデン−5−フルオロウリジン(収 率:理論量の97%)を含む有機相を、小体積になるまで減圧濃縮する。残渣に56 0mlの80%水性酢酸を添加し、混合物を95℃に加熱する。4時間加熱した後、H PLCによる確認を行う(0.34%の残留出発物質)。冷却後、混合物を、油状残渣 が得られるまで減圧濃縮し、これを150mlの酢酸エチルに吸収させる。混合物を2 0〜25℃で15時間放置する。生成物を濾過し、酢酸エチルで洗浄し、45℃で減圧 乾燥する。こうして、44.5gの5'−デオキシ−5'−ヨード−5−フルオロウリ ジンが得られる。融点=174〜175℃、純度(HPLC)=99.74%および[α]D= +8.96°(c=1、CH3OH)。母液を 減圧濃縮し、残渣を50mlの酢酸エチルに吸収させる。+5℃で15時間後、さらに 3.3gの生成物が得られる。総収率:理論量の83%。 B.5'−デオキシ−5−フルオロウリジン エタノール60mlおよびイソプロパノール40mlの混合物中の5'−デオキシ−5' −ヨード−5−フルオロウリジン20g(0.053m)の懸濁物に、15.2ml(0.108m )のジイソプロピルアミンを添加し、次いで、3gの5%Pd/Cをその中に添 加し、混合物を約1バールの圧力で14時間水素添加する。触媒を濾去した後、固 体残渣が得られるまで溶液を減圧濃縮し、これをエタノール/イソプロパノール =60/40v/vの混合物で結晶化させる。8時間後、生成物を濾過し、前記混合物 で洗浄し、45℃で15時間乾燥させる。こうして、11.6g(収率:理論量の89%) の5'−デオキシ−5−フルオロウリジンが得られる。融点=187〜188℃、純度 (HPLC)=99.75%および[α]D=+18.2°(c=0.42、H2O)。 実施例3 実施例1に記載したようにして得られた2',3'−O−イソプロピリデン−5 '−O−(p−トルエンスルホニル)−5−フルオロウリジン40g(0.087m)の アセトン1700ml中の溶液に105gのヨウ化ナトリウムを添加し、こうして得られ た透明溶液を還流下で4〜5時間加熱する。次いで、混合物を冷却し、濾過し、 アセトンで洗浄する。アセトン溶液を集めて減圧濃縮し、残渣を3500mlの酢酸 エチルに吸収させる。メタ重亜硫酸ナトリウムの3%水性溶液500ml、次いで水 で洗浄した後、酢酸エチル溶液を小体積になるまで濃縮する。15時間後、沈殿を 濾過し、乾燥させると、33.2gの5'−デオキシ−5'−ヨード−2',3'−O− イソプロピリデン−5−フルオロウリジンが白色結晶粉末として得られる。融点 =199〜202℃、純度(HPLC)=99.9%および[α]D=−16.8°(c=0.50、 CH3OH)。 実施例4 A.5'−デオキシ−5'−ヨード−5−フルオロウリジン 酢酸500mlおよび水120ml中の5'−デオキシ−5'−ヨード−2',3'−O−イ ソプロピリデン−5−フルオロウリジン51g(0.105m)の懸濁物を95℃で90分間 加熱する。こうして得られた溶液を減圧濃縮し、残渣を2リットルの酢酸エチル に吸収させ、次いで、小体積になるまで濃縮し、室温で15時間後、沈殿を濾過し 、酢酸エチルで洗浄し、乾燥させると、35.6gの5'−デオキシ−5'−ヨード− 5−フルオロウリジンが得られる。融点=174.5〜175.5℃、純度(HPLC)= 99.74%および[α]D=+8.96°(c=1.00、CH3OH)。 B.5'−デオキシ−5−フルオロウリジン メタノール1100ml中の5'−デオキシ−5'−ヨード−5−フルオロウリジン35 .1g(0.078m)およびα,α’−アゾイソブチロニトリル2.93gの溶液に、ト ルエン310ml中の水素化トリブチルスズ37.4gの溶液を添加する。 混合物を還流下で2時間加熱し、こうして得られた透明溶液を半固体残渣が得ら れるまで減圧濃縮し、これを900mlの石油エーテルに分散させる。固体を濾過し 、1200mlの水で処理する。スズ塩を濾別し、濾液を減圧濃縮する。残渣を500ml の熱エーテルで結晶化させると、12.3gの5'−デオキシ−5−フルオロウリジ ンが得られる。融点=188〜189℃、純度(HPLC)=99.91%および[α]D= +18.4°(c=0.42、H2O)。 実施例5 実施例2の工程Aに記載したようにして得られた5'−デオキシ−5'−ヨード −5−フルオロウリジン10g(0.026m)のn−ブタノール100ml中の懸濁物に、6 mlのシクロヘキセン(0.06m)および14ml(0.1m)のトリエチルアミンを添加する 。完全な溶解を達成するために混合物を60℃に加熱し、次いで、1.5gの5%P d/Cをその中に添加する。懸濁物を80℃で5時間加熱し、熱n−ブタノールで 洗浄することにより同じ温度で濾過し、残渣が得られるまで減圧濃縮し、これを 60mlのエタノールおよび40mlのイソプロパノールの混合物で結晶化させる。こう して、4.5gの5'−デオキシ−5−フルオロウリジンが得られる。融点=188〜1 89℃、純度(HPLC)=99.87%および[α]D=18.35°(c=0.42、H2O)。DETAILED DESCRIPTION OF THE INVENTION TECHNICAL FIELD The present invention deoxyuridine derivatives, process for the preparation of deoxyuridine derivatives. More particularly, the present invention relates to 5'-deoxy-5-fluorouridine and a process for the preparation of novel intermediates useful in this process. The compound 5'-deoxy-5-fluorouridine is a well-known cytostatic, as will be indicated below by its International Nonproprietary Name doxiffluridine. Doxyfluridine with formula I is No. 4,071,680, which discloses a multi-step synthesis starting from 5-fluorouridine and involving removal of the 5'-hydroxy group through the corresponding 5'-iodine derivative. Is also disclosed. According to this document, the replacement of the 5'-hydroxy group by an iodine atom requires triphenylphosphite as a chemical iodinating agent, which requires particular attention due to the toxicity of the reagent due to the presence of reaction by-products. This is achieved by using meso-iodide. EP 21,231 discloses the preparation of doxyfluridine by removal of the acyl group from the corresponding 2 ', 3'-diester with a carboxylic acid, especially the corresponding 2', 3'-diacetate. I have. However, the synthesis of the starting material involves the replacement of the hydroxy group by a bromine atom and the conversion of the bromine derivative to the corresponding deoxy compound by catalytic hydrogenation. Also in this case, the bromination is carried out using a fluorescent compound, ie with bromine in the presence of large amounts of triphenylphosphine. S. Aymera and P.M. V. According to a paper by Danenberg (J. Med. Chem. 1982, 25, p. 999), 5′-deoxy-5′-iodo-2 ′, 3′-O-isopropylidene-5-fluorouridine is Prepared according to the method of Cook et al. (J. Med. Chem. 1979, 22, 1330, corresponding to U.S. Pat. No. 4,071,680). The same article describes the conversion of 5'-deoxy-5'-O-mesyloxy-2 ', 3'-O-isopropylidene-5-fluorouridine by lithium bromide to 5'-bromo-5'-deoxy-2', It discloses converting to 3'-O-isopropylidene-5-fluorouridine, but does not disclose any further conversion. On the other hand, in EP 21 231, cited above, the replacement of a bromine atom by a hydrogen atom is carried out under strong conditions, ie on catalytic hydrogenation in the presence of potassium hydroxide on a substrate not containing a uracil moiety. Wherein one is introduced after the production of the deoxysugar in the presence of a strong inorganic base. If the hydroxy group of 2 ', 3'-isopropylidene-5-fluorouridine is preactivated, such as a sulfonic ester, simply use sodium iodide in the absence of any fluorescent compound. It has now been found that the iodine atom can replace the hydroxyl group of 2 ', 3'-isopropylidene-5-fluorouridine. The iodine atom of 5'-deoxy-5'-iodo-2 ', 3'-O-isopropylidene-5-fluorouridine can be replaced by a hydrogen atom by catalytic hydrogenation without using a strong base. Thus, it has also been found that the corresponding 5'-deoxy compounds are obtained in very good yields. The same substitution can take place with other hydrogen donors, for example cyclohexene, cyclohexadiene or hydrides, for example tributyltin hydride. Thus, (a) 2 ′, 3′-O-isopropylidene-5-fluorouridine of formula II Is a functional derivative of a sulfonic acid of formula III Wherein R is (C 1 -C 4 ) alkyl, trifluoromethyl, an unsubstituted phenyl group, or a mono-, di- or tri-substituted phenyl group. 5'-sulfonyloxy derivatives of the formula IV thus obtained (Where R is the same as above) with an alkali metal iodide or an alkaline earth metal iodide, (c) 5′-deoxy-5′- of formula V thus obtained Iodo-2 ', 3'-O-isopropylidene-5-fluorouridine Is hydrolyzed in an acidic medium, and (d) 5'-deoxy-5'-iodo-5-fluorouridine of formula VI It is an object of the present invention to provide a process for the preparation of 5'-deoxy-5-fluorouridine, which comprises subjecting to a reduction with hydrogen or a hydrogen donor. In Formula III, R is preferably methyl, ethyl, n-butyl, trifluoromethyl, phenyl, monosubstituted phenyl, i.e., phenyl monosubstituted by methyl, methoxy, nitro or halogen, disubstituted. Phenyl, ie, phenyl disubstituted by two methyl groups, or phenyl trisubstituted, ie, phenyl trisubstituted by three methyl groups, especially phenyl 2,4,6-trisubstituted . Chloride, acid anhydrides or mixed acid anhydrides are suitably used as functional derivatives of the sulfonic acids. Methanesulfonyl chloride, benzenesulfonyl chloride, p-toluenesulfonyl chloride, trifluoromethanesulfonyl chloride and 2,4,6-trimethylphenylsulfonyl chloride are particularly preferred as esterifying agents. Thus, in step (a), preferably the functional derivative of the sulfonic acid of formula III selected from the group consisting of those defined above is 2 ′, 3′-O-isopropylidene-5- React with fluorouridine. Advantageously, the reaction is carried out in an organic solvent, i.e. a halogenated solvent such as dichloromethane, 1,2-dichloroethane or 1,1,1-trichloroethane, or a polar aprotic solvent such as N, N-dimethylformamide, N, N-dimethylacetamide, dimethylsulfoxide or acetonitrile, or ethyl acetate or an aromatic hydrocarbon, such as toluene or xylene, in a base such as trimethylamine, triethylamine, diisopropylamine, N-ethyl-diisopropylamine, pyridine or dimethyl Performed in the presence of aminopyridine. Usually, after 5-6 hours at a temperature of 0 ++ 40 ° C., the reaction is complete, and the compound of formula IV thus obtained is treated with water followed by simple filtration of the reaction by-products. Separated from things. The 5'-sulfonyloxy derivative of formula IV can be recovered by extraction with an organic solvent, followed by concentration, and can be isolated and characterized according to conventional methods. Alternatively, a concentrated solution of the compound of formula IV may be used directly for step (b). Step (b) comprises reacting the compound of formula IV in pure form or as said concentrated solution obtained at the end of step (a) with a ketone, preferably acetone, methyl ethyl ketone or methyl isobutyl ketone, ether, Preferably alkali or alkaline earth in an organic solvent such as dioxane or tetrahydrofuran or a polar aprotic solvent, preferably acetonitrile, N, N-dimethylformamide, N, N-dimethylacetamide or dimethylsulfoxide. The treatment is carried out simply using an antideide. After 4-6 hours at a temperature of 40-80 ° C., the reaction is complete, as in step (a), by-products of the reaction are removed by filtration and washed with water. The expected end product, i.e., 5'-deoxy-5'-iodo-2 ', 3'-O-isopropylidene-5-fluorouridine of formula V, is recovered using an organic solvent, preferably ethyl acetate. , Then concentrated and isolated according to conventional methods. As in step (a), the concentrated solution containing the compound of formula V may be used directly for step (c). Step (c) comprises 5′-deoxy-5′-iodo-2 ′, 3′-O-isopropylidene-5-fluorouridine, according to methods customary in the field of sugar chemistry, more particularly in the field of nucleosides. In an acidic medium. Preferably, the hydrolysis is carried out in aqueous formic acid or, more advantageously, in aqueous acetic acid or in N, N-dimethylformamide or N, N-dimethylacetamide, in aqueous hydrogen chloride. At 80-100 ° C in the presence of The 5'-deoxy-5'-iodo-5-fluorouridine of formula VI thus obtained is isolated by evaporating the solvent, and the compound is recovered by extraction from a suitable solvent, preferably ethyl acetate. You. As mentioned above, the compounds obtained at the end of steps (a) and (b) may be isolated and identified, or preferably, they are isolated, neat, or solvent May be used in the form of a solution or suspension. The yields of the three steps are very high, i.e. always greater than 90% of theory, and the compound of the formula VI has the starting material 2 ', 3'-O-isopropylidene-5-fluorouridine of the formula II Based on the calculation, it can be recovered as high as 83-85%. In step (d), the compound of formula VI is subjected to a reduction, which is carried out by catalytic hydrogenation or using cyclohexane or cyclohexadiene as a hydrogen donor, for example as a catalyst, preferably with 5% Pd / C Or in the presence of hydrides. The reduction is carried out in an organic solvent, for example in an alcohol, for example methanol, ethanol, propanol, isopropanol or n-butanol or a mixture thereof. Preferably, an organic base such as trimethylamine, triethylamine, diisopropylamine, N-ethyldiisopropylamine, pyridine, dimethylaminopyridine, morpholine, N-methylmorpholine, 2-picoline, and quinone, or an inorganic base such as alkali bicarbonate Salts, such as sodium bicarbonate or potassium bicarbonate, are present in the reaction mixture. If the reduction is carried out with hydrogen, the hydrogenation takes place at room temperature or at a pressure of 1-2 bar and room temperature in the presence of 5% Pd / C. If the reduction is carried out in the presence of a hydrogen donor, for example cyclohexane, cyclohexadiene or a hydride, for example tributyltin hydride, the reaction is carried out in an alcoholic solvent, for example methanol, ethanol, isopropanol, n-butanol, It is carried out in isobutanol or the like, or in a mixture of the above solvent and an aprotic solvent, for example, toluene. More particularly, if the reduction is carried out at 60-90 ° C. with cyclohexane or cyclohexadiene as hydrogen donor, it is complete after 3-6 hours. The 5'-deoxy-5-fluorouridine thus obtained is isolated according to conventional methods, more particularly by filtering the catalyst and evaporating the solvent. The final product is crystallized using an ethanol / isopropanol = 3/2 (vol / vol) mixture. When the reduction is carried out using tributyltin hydride, the reaction is carried out by dissolving 5′-deoxy-5′-iodo-5-fluorouridine in an alcohol, for example methanol, and adding the reducing agent in an organic solvent. For example, in toluene, and the reaction mixture is heated to reflux in the presence of a catalytic amount of α, α′-azoisobutyronitrile. After 1-3 hours, the reaction is complete, and after evaporation of the solvent, the 5'-deoxy-5-fluorouridine thus obtained is recovered according to conventional methods. According to a preferred embodiment of the invention, steps (a), (b) and (c) are performed without isolation of the product obtained at the end of each of steps (a) and (b). In this way, the method of the invention makes it possible to prepare doxifluridine very easily and in very high yields. In addition, the method may be performed in a one-pot technique for steps (a), (b) and (c). The method is depicted in Scheme I, wherein R is (C 1 ~C 4) alkyl, trifluoromethyl, unsubstituted or mono-, - di - is or tri-substituted phenyl. Scheme 1 The following examples illustrate the invention without limiting it. Example 1 To a solution of 80 g (0.26 m) of 2 ', 3'-O-isopropylidene-5-fluorouridine in 700 ml of pyridine, cooled to about + 5 ° C, 90.6 g (0.48 m) of p -Toluenesulfonyl chloride was added. The resulting mixture was stirred for 5 hours, then 10 liters of water were added slowly, and the aqueous suspension was stirred for 3 hours. The mixture was left at room temperature for 15 hours, then the precipitate was filtered, washed with water and dried. The crystalline form of 2 ', 3'-O-isopropylidene-5'-O- (p-toluenesulfonyl) -5-fluorouridine was thus obtained. M. p. = 154-156 ° C; purity (HPLC) = 99.89% and [α] D = + 26.71 ° (c = 1, CH 3 OH). The product thus obtained is crystallized using ethanol to obtain a white crystalline powder. M.p. = 156-158 ° C; purity = 99.9-100% (HPL C). Example 2 A. 5'-Deoxy-5'-iodo-5-fluorouridine A solution of 39.2 g (0.13 m) of 2 ', 3'-O-isopropylidene-5-fluorouridine in 55 ml of methylene chloride and 159 ml (1.98 m) of pyridine was prepared. After cooling to + 5 ° C, 60 g (0.315 m) of p-toluenesulfonyl chloride are added. When the thus obtained mixture is stirred for 5 hours, formation of a large amount of precipitate is observed. Then 160 ml of methylene chloride and 160 ml of water are added therein, whereby the temperature rises to 40 ° C. The phases are separated and the organic phase is extracted with about 900 ml of 1N HCl. The organic phase is then washed with 2 × 100 ml of water. An oily residue was obtained from an organic phase containing 0.117 m of 2 ', 3'-O-isopropylidene-5'-O- (p-toluenesulfonyl) -5-fluorouridine (yield: 90% of theory). Concentrate under reduced pressure until complete and take up in 2 × 100 ml of acetone. The oily residue is dissolved in 600 ml of acetone and 105 g (0.70 m) of sodium iodide are added to the solution. The mixture is heated under reflux for 5 hours, then cooled and concentrated under reduced pressure, and the residue thus obtained is taken up in 2 × 80 ml of ethyl acetate. The residual oil is treated with 800 ml of ethyl acetate and 100 ml of water. The phases are separated and the aqueous layer is treated with 2.times.80 ml of ethyl acetate. The combined organic phases are washed with 2.times.100 ml of a 5% aqueous solution of sodium metabisulfite and then with 100 ml of water. The organic phase containing 0.113 m of 5'-deoxy-5'-iodo-2 ', 3'-O-isopropylidene-5-fluorouridine (yield: 97% of theory) is depressurized to a small volume. Concentrate. To the residue is added 560 ml of 80% aqueous acetic acid and the mixture is heated to 95 ° C. After heating for 4 hours, confirmation by HPLC is performed (0.34% residual starting material). After cooling, the mixture is concentrated in vacuo until an oily residue is obtained, which is taken up in 150 ml of ethyl acetate. The mixture is left at 20-25 ° C. for 15 hours. The product is filtered, washed with ethyl acetate and dried at 45 ° C. under reduced pressure. Thus, 44.5 g of 5'-deoxy-5'-iodo-5-fluorouridine are obtained. Melting point = 174-175 ° C, purity (HPLC) = 99.74% and [α] D = + 8.96 ° (c = 1, CH 3 OH). The mother liquor is concentrated under reduced pressure and the residue is taken up in 50 ml of ethyl acetate. After 15 hours at + 5 ° C., an additional 3.3 g of product is obtained. Total yield: 83% of theory. B. 5'-Deoxy-5-fluorouridine To a suspension of 20 g (0.053 m) of 5'-deoxy-5'-iodo-5-fluorouridine in a mixture of 60 ml of ethanol and 40 ml of isopropanol was added 15.2 ml (0.108 m) of the suspension. Diisopropylamine is added, then 3 g of 5% Pd / C are added therein and the mixture is hydrogenated at a pressure of about 1 bar for 14 hours. After filtering off the catalyst, the solution is concentrated under reduced pressure until a solid residue is obtained, which is crystallized from a mixture of ethanol / isopropanol = 60/40 v / v. After 8 hours, the product is filtered, washed with the mixture and dried at 45 ° C. for 15 hours. This gives 11.6 g (yield: 89% of theory) of 5'-deoxy-5-fluorouridine. Mp = 187~188 ℃, purity (HPLC) = 99.75% and [α] D = + 18.2 ° (c = 0.42, H 2 O). Example 3 40 g (0.087 m) of 2 ', 3'-O-isopropylidene-5'-O- (p-toluenesulfonyl) -5-fluorouridine obtained as described in Example 1 in 1700 ml of acetone 105 g of sodium iodide are added to the solution therein and the clear solution thus obtained is heated under reflux for 4-5 hours. Then the mixture is cooled, filtered and washed with acetone. The acetone solution is collected, concentrated under reduced pressure, and the residue is taken up in 3500 ml of ethyl acetate. After washing with 500 ml of a 3% aqueous solution of sodium metabisulfite and then with water, the ethyl acetate solution is concentrated to a small volume. After 15 hours, the precipitate is filtered and dried, giving 33.2 g of 5'-deoxy-5'-iodo-2 ', 3'-O-isopropylidene-5-fluorouridine as a white crystalline powder. Mp = 199-202 ° C., purity (HPLC) = 99.9% and [α] D = -16.8 ° ( c = 0.50, CH 3 OH). Example 4 A. 5'-Deoxy-5'-iodo-5-fluorouridine 51 g of 5'-deoxy-5'-iodo-2 ', 3'-O-isopropylidene-5-fluorouridine in 500 ml of acetic acid and 120 ml of water (0.105 m ) Is heated at 95 ° C. for 90 minutes. The solution thus obtained is concentrated under reduced pressure, the residue is taken up in 2 l of ethyl acetate and then concentrated to a small volume, after 15 hours at room temperature, the precipitate is filtered, washed with ethyl acetate and dried. This gives 35.6 g of 5'-deoxy-5'-iodo-5-fluorouridine. Mp = 174.5 to 175.5 ° C., purity (HPLC) = 99.74% and [α] D = + 8.96 ° (c = 1.00, CH 3 OH). B. 5'-Deoxy-5-fluorouridine To a solution of 35.1 g (0.078 m) of 5'-deoxy-5'-iodo-5-fluorouridine and 2.93 g of α, α'-azoisobutyronitrile in 1100 ml of methanol. A solution of 37.4 g of tributyltin hydride in 310 ml of toluene is added. The mixture is heated under reflux for 2 hours and the clear solution thus obtained is concentrated under reduced pressure until a semi-solid residue is obtained, which is dispersed in 900 ml of petroleum ether. The solid is filtered and treated with 1200 ml of water. The tin salt is filtered off, and the filtrate is concentrated under reduced pressure. The residue is crystallized from 500 ml of hot ether to give 12.3 g of 5'-deoxy-5-fluorouridine. Mp = 188~189 ℃, purity (HPLC) = 99.91% and [α] D = + 18.4 ° (c = 0.42, H 2 O). Example 5 To a suspension of 10 g (0.026 m) of 5'-deoxy-5'-iodo-5-fluorouridine obtained as described in step A of Example 2 in 100 ml of n-butanol was added 6 Add ml of cyclohexene (0.06 m) and 14 ml (0.1 m) of triethylamine. The mixture is heated to 60 ° C. to achieve complete dissolution, then 1.5 g of 5% Pd / C is added therein. The suspension is heated at 80 ° C. for 5 hours, filtered at the same temperature by washing with hot n-butanol and concentrated under reduced pressure until a residue is obtained, which is crystallized from a mixture of 60 ml of ethanol and 40 ml of isopropanol. Let it. This gives 4.5 g of 5'-deoxy-5-fluorouridine. Mp = 188~1 89 ℃, purity (HPLC) = 99.87% and [α] D = 18.35 ° ( c = 0.42, H 2 O).
───────────────────────────────────────────────────── フロントページの続き (81)指定国 EP(AT,BE,CH,CY, DE,DK,ES,FI,FR,GB,GR,IE,I T,LU,MC,NL,PT,SE),OA(BF,BJ ,CF,CG,CI,CM,GA,GN,ML,MR, NE,SN,TD,TG),AP(GH,GM,KE,L S,MW,SD,SZ,UG,ZW),EA(AM,AZ ,BY,KG,KZ,MD,RU,TJ,TM),AL ,AM,AT,AU,AZ,BA,BB,BG,BR, BY,CA,CH,CN,CU,CZ,DE,DK,E E,ES,FI,GB,GE,GH,GM,GW,HU ,ID,IL,IS,JP,KE,KG,KP,KR, KZ,LC,LK,LR,LS,LT,LU,LV,M D,MG,MK,MN,MW,MX,NO,NZ,PL ,PT,RO,RU,SD,SE,SG,SI,SK, SL,TJ,TM,TR,TT,UA,UG,US,U Z,VN,YU,ZW (72)発明者 モンキアルディニ,シモーネ イタリア国,21100 バレセ,ビア マル コビ,10 (72)発明者 オルダニーニ,ジャンカルロ イタリア国,21039 ベデロ バルキュビ ア,ロカリタ カルボラ(番地なし)────────────────────────────────────────────────── ─── Continuation of front page (81) Designated country EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, I T, LU, MC, NL, PT, SE), OA (BF, BJ , CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG), AP (GH, GM, KE, L S, MW, SD, SZ, UG, ZW), EA (AM, AZ , BY, KG, KZ, MD, RU, TJ, TM), AL , AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, E E, ES, FI, GB, GE, GH, GM, GW, HU , ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, M D, MG, MK, MN, MW, MX, NO, NZ, PL , PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, U Z, VN, YU, ZW (72) Inventor Monki Aldini, Simone Italy, 21100 Barese, Via Mar Kobi, 10 (72) Inventor Aldanini, Giancarlo 21039 Bedero Barcubi, Italy A, Locita Carbola (No address)
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001211A IT1291983B1 (en) | 1997-05-23 | 1997-05-23 | PRODUCTION FOR THE PREPARATION OF A DESOXYURIDINE DERIVATIVE |
IT97A001211 | 1997-05-23 | ||
PCT/EP1998/003171 WO1998052960A1 (en) | 1997-05-23 | 1998-05-21 | Process for the preparation of a deoxyuridine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001525843A true JP2001525843A (en) | 2001-12-11 |
JP2001525843A5 JP2001525843A5 (en) | 2005-12-08 |
Family
ID=11377203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54999498A Withdrawn JP2001525843A (en) | 1997-05-23 | 1998-05-21 | Method for producing deoxyuridine derivative |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0984976B1 (en) |
JP (1) | JP2001525843A (en) |
KR (1) | KR100495556B1 (en) |
CN (1) | CN1184228C (en) |
AU (1) | AU733033B2 (en) |
BR (1) | BR9809158A (en) |
CA (1) | CA2292754C (en) |
DE (1) | DE69808457T2 (en) |
ES (1) | ES2184301T3 (en) |
HU (1) | HUP0002114A3 (en) |
IT (1) | IT1291983B1 (en) |
NO (1) | NO312593B1 (en) |
PL (1) | PL187648B1 (en) |
PT (1) | PT984976E (en) |
RU (1) | RU2204564C2 (en) |
TR (1) | TR200000245T2 (en) |
WO (1) | WO1998052960A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101054398B (en) * | 2006-04-11 | 2012-05-30 | 上海迪赛诺医药发展有限公司 | Method of synthesizing 2-deoxy-5-iodo-beta-uridine |
CN102161686A (en) * | 2011-02-26 | 2011-08-24 | 湖南欧亚生物有限公司 | Method for preparing doxifluridine |
CN102344469A (en) * | 2011-07-26 | 2012-02-08 | 江西科技师范学院 | Method for synthesizing 1,2, 3-O-triacetyl-5-deoxy-D-ribofuranose by catalysis of solid acid SO4 2-/γ-AL2O3 |
CN102827902B (en) * | 2012-03-27 | 2013-12-18 | 浙江工业大学 | Method for preparing 2'-deoxyuridine by chemical-biological enzyme method in combination |
CN105315318B (en) * | 2015-11-06 | 2019-04-19 | 山东大学 | A kind of alpha-L-Rhamnosidase is preparing the application in the fluoro- 2 '-deoxidation urea glycoside derivates of 5- |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4071680A (en) * | 1976-12-20 | 1978-01-31 | Hoffmann-La Roche Inc. | 5'-Deoxy-5-fluoropyrimidine nucleosides |
CA1135258A (en) * | 1979-06-15 | 1982-11-09 | Richard D'souza | Process for the preparation of 5'deoxy-5-fluorouridine |
-
1997
- 1997-05-23 IT IT97MI001211A patent/IT1291983B1/en active IP Right Grant
-
1998
- 1998-05-21 KR KR10-1999-7010872A patent/KR100495556B1/en not_active IP Right Cessation
- 1998-05-21 CN CNB988065290A patent/CN1184228C/en not_active Expired - Fee Related
- 1998-05-21 RU RU99128044/04A patent/RU2204564C2/en not_active IP Right Cessation
- 1998-05-21 BR BR9809158-1A patent/BR9809158A/en not_active Application Discontinuation
- 1998-05-21 JP JP54999498A patent/JP2001525843A/en not_active Withdrawn
- 1998-05-21 DE DE69808457T patent/DE69808457T2/en not_active Expired - Fee Related
- 1998-05-21 PL PL98337006A patent/PL187648B1/en not_active IP Right Cessation
- 1998-05-21 WO PCT/EP1998/003171 patent/WO1998052960A1/en active IP Right Grant
- 1998-05-21 PT PT98934903T patent/PT984976E/en unknown
- 1998-05-21 CA CA002292754A patent/CA2292754C/en not_active Expired - Fee Related
- 1998-05-21 ES ES98934903T patent/ES2184301T3/en not_active Expired - Lifetime
- 1998-05-21 AU AU84351/98A patent/AU733033B2/en not_active Ceased
- 1998-05-21 HU HU0002114A patent/HUP0002114A3/en unknown
- 1998-05-21 EP EP98934903A patent/EP0984976B1/en not_active Expired - Lifetime
- 1998-05-21 TR TR2000/00245T patent/TR200000245T2/en unknown
-
1999
- 1999-11-23 NO NO19995750A patent/NO312593B1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ITMI971211A0 (en) | 1997-05-23 |
KR100495556B1 (en) | 2005-06-16 |
CA2292754C (en) | 2006-02-07 |
PT984976E (en) | 2003-01-31 |
ES2184301T3 (en) | 2003-04-01 |
TR200000245T2 (en) | 2000-06-21 |
NO995750L (en) | 2000-01-19 |
WO1998052960A1 (en) | 1998-11-26 |
IT1291983B1 (en) | 1999-01-25 |
EP0984976B1 (en) | 2002-10-02 |
CN1184228C (en) | 2005-01-12 |
AU733033B2 (en) | 2001-05-03 |
CN1261371A (en) | 2000-07-26 |
DE69808457T2 (en) | 2003-07-03 |
CA2292754A1 (en) | 1998-11-26 |
KR20010012905A (en) | 2001-02-26 |
NO312593B1 (en) | 2002-06-03 |
NO995750D0 (en) | 1999-11-23 |
DE69808457D1 (en) | 2002-11-07 |
ITMI971211A1 (en) | 1998-11-23 |
HUP0002114A3 (en) | 2002-01-28 |
HUP0002114A1 (en) | 2000-11-28 |
RU2204564C2 (en) | 2003-05-20 |
PL187648B1 (en) | 2004-08-31 |
EP0984976A1 (en) | 2000-03-15 |
AU8435198A (en) | 1998-12-11 |
BR9809158A (en) | 2000-08-01 |
PL337006A1 (en) | 2000-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008144980A1 (en) | The preparation method and intermediates of capecitabine | |
CZ545190A3 (en) | Process for preparing novel 2', 3'-dideoxy-2'-fluoronucleosides | |
JP4593917B2 (en) | Method for preparing purine nucleosides | |
JP2001525843A (en) | Method for producing deoxyuridine derivative | |
JPH0797391A (en) | Nucleoside derivative and its production | |
JP4603274B2 (en) | Process for producing 2'-deoxy-5-trifluoromethyluridine | |
JP3128080B2 (en) | Novel method for producing nucleic acid compounds | |
US6593467B2 (en) | Process for the preparation of a deoxyuridine derivative | |
CA2054419C (en) | Process for producing 6-(3-dimethylaminopropionyl)forskolin | |
CA2545437A1 (en) | Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives | |
JPH0524908B2 (en) | ||
CN112209976B (en) | Decitabine intermediate compound V | |
JPH07165785A (en) | Preparation of 3'-fluoropyrimidine nucleoside | |
JP2005538080A (en) | Method for synthesizing 2-deoxy-L-ribose | |
JPS5832867A (en) | Novel arylazopyrimidine compound | |
JP3023804B2 (en) | Method for producing 3'-deoxy-3'-fluorothymidine | |
JPH0154359B2 (en) | ||
JP3123238B2 (en) | Purification method of nucleoside derivative | |
CN103443095A (en) | Method for preparing zidovudine and intermediate thereof | |
JP2504934B2 (en) | 1,6,7-Triacylforskolin derivative | |
TW491850B (en) | Process for preparing etoposide | |
CN1324800A (en) | Prepn. of 2',3'-didehydro-3'-deoxythymidine | |
JPH0567153B2 (en) | ||
JPS5943480B2 (en) | organic germanium compounds | |
JPWO2006137447A1 (en) | Stable crystals of protected pseudouridine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050425 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050425 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20070525 |